FIELD: pharmaceutical chemistry.
SUBSTANCE: invention relates to drugs for prevention and treatment of a variety of viral proliferative diseases and immunity disorders. Proposed solution contains: high-purity alpha-interferon; inert polymeric filler (in particular dextran or rheopolyglucin with molecular mass of dextran 30-50 kD); nonionic surfactant: tween 80, ethylenediaminetetraacetic acid or sodium salt thereof; buffer system including sodium acetate to provide solution pH 4.5-5.5; sodium chloride as osmotic pressure regulator; and injection water, all in specified proportions.
EFFECT: prolonged high activity and stability of preparation (up to 30 months) and improved quality characteristics thereof.
2 cl, 5 tbl, 2 ex
